retatrutide efficacy clinical trials approval: FDA status, trial results, and when it could be available Retatrutide vs Tirzepatide (2026): Differences

FDA approval for Retatrutide as a pharmaceutical product is projected for 2026 to 2027, so prescription access through traditional channels remains a year or more away

Larger database signals

[PubMed] Thomas MK, Nikooienejad A, Bray R, et al

This triple action aids insulin sensitivity, appetite control, and fat loss

Retatrutide x 10 Vials is not intended for human consumption, veterinary use, self-administration, clinical use, treatment, diagnosis, prevention, cosmetic use, supplement use, body composition use, wellness use, weight-loss use or any form of personal use

The glucagon component is the part that neither Mounjaro nor Wegovy has